文献速递心力衰竭与心肌病

多组学分析揭示心力衰竭进展相关的新通路

Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

研究整合基因组、转录组和蛋白质组数据,用机器学习模型在BIOSTAT-CHF队列2516例心衰患者中建模全因死亡,并在1738例独立队列中验证。中位随访21个月期间657例(26%)死亡,鉴定出PI3K/Akt、MAPK、Ras信号通路及EGFR酪氨酸激酶抑制剂耐药四条与全因死亡显著相关的通路,均与心脏保护性ERBB2受体激活降低相关,可被神经调节蛋白修饰。

要点

  • 整合多组学与机器学习可识别心衰死亡相关通路。
  • PI3K/Akt、MAPK、Ras及EGFR-TKI耐药通路与全因死亡显著相关。
  • 上述通路与ERBB2受体激活降低相关,神经调节蛋白可修饰。

核心结论

  • 系统生物学方法整合基因组、转录组和蛋白质组数据,鉴定出4条与心衰患者死亡相关的主要通路。
  • 这些通路与心脏保护性ERBB2受体激活降低相关,该受体可被神经调节蛋白修饰。

研究设计与样本

  • 基于BIOSTAT-CHF研究,采用堆叠泛化框架与梯度提升算法的机器学习方法。
  • 结果在1738例独立队列中验证。

主要发现

  • 患者平均年龄70岁(Q1-Q3:61-78岁),27%为女性,NT-proBNP中位数4275 ng/L(Q1-Q3:2360-8486 ng/L),7%为射血分数保留的心衰。
  • 中位随访21个月期间,657例(26%)患者死亡。
  • 与全因死亡显著相关的4条主要通路为:PI3K/Akt通路、MAPK通路、Ras信号通路和表皮生长因子受体酪氨酸激酶抑制剂耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite major advances in pharmacological treatment for patients with heart failure, residual mortality remains high. This suggests that important pathways are not yet targeted by current heart failure therapies. OBJECTIVES: We sought integration of genetic, transcriptomic, and proteomic data in a large cohort of patients with heart failure to detect major pathways related to progression of heart failure leading to death. METHODS: We used machine learning methodology based on stacked generalization framework and gradient boosting algorithms, using 54 clinical phenotypes, 403 circulating plasma proteins, 36,046 transcript expression levels in whole blood, and 6 million genomic markers to model all-cause mortality in 2,516 patients with heart failure from the BIOSTAT-CHF (Systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure) study. Results were validated in an independent cohort of 1,738 patients. RESULTS: The mean age of the patients was 70 years (Q1-Q3: 61-78 years), 27% were female, median N-terminal pro-B-type natriuretic peptide was 4,275 ng/L (Q1-Q3: 2,360-8,486 ng/L), and 7% had heart failure with preserved ejection fraction. During a median follow-up of 21 months, 657 (26%) of patients died. The 4 major pathways with a significant association to all-cause mortality were: 1) the PI3K/Akt pathway; 2) the MAPK pathway; 3) the Ras signaling pathway; and 4) epidermal growth factor receptor tyrosine kinase inhibitor resistance. Results were validated in an independent cohort of 1,738 patients. CONCLUSIONS: A systems biology approach integrating genomic, transcriptomic, and proteomic data identified 4 major pathways related to mortality. These pathways are related to decreased activation of the cardioprotective ERBB2 receptor, which can be modified by neuregulin.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ouwerkerk, Belo Pereira, Maasland, et al. Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure. J Am Coll Cardiol. 2023. PMID: 37940229. doi:10.1016/j.jacc.2023.08.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。